The 2018 Clinical Cancer Advances report of the American Society of Clinical Oncology has crowned an adoptive cell immunotherapy as its Advance of the Year. What is this innovative cancer treatment? What are the risks and benefits?
Did you know that scientists can use samples from our bodies to learn more about cancer and how to treat it? These samples are called biospecimens, and people can donate them to help make progress in cancer research regardless of whether they have cancer.
In this podcast, Cancer.Net Associate Editor Ezra Cohen, MD, FRCPC, discusses some of the key themes that arose at the 2017 3rd World Congress on Thyroid Cancer.
ASCO Annual Meeting 2017: Symptom Reporting Extends Lives, Shorter Chemotherapy for Some Colon Cancer Patients, and Targeted Therapy in BRCA-Related Breast Cancer
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research released today covers how using a web-based system to report symptoms helps patients live longer, a shorter schedule of chemotherapy can be an option for certain people with colon cancer, and a targeted therapy may slow the growth of BRCA-related breast cancer.
ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.
In this podcast, certified genetic counselor Tiffani DeMarco answers common questions about genetic counseling and explains what the future may hold for genetic testing.
Genetic testing can identify inherited risks for some types of cancer. The results of these tests affect both you and your family. Here are some things to think about when sharing genetic test results.
The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively.
Donating bone marrow can be as easy and painless as giving blood. Here’s what you need to know about the life-saving tissue inside your bones and the current donation process.
Recent FDA approvals for immunotherapy drugs for treating lung cancer are exciting, but there still are many things we need to learn about this new field of cancer treatment. Cancer.Net Associate Editor Jyoti Patel, MD, answers some of the questions that surround lung cancer and immunotherapy, during Lung Cancer Awareness Month.